Importantly, the combination of ezrin inhibitor NSC305787 and vemurafenib at low sub-toxic concentrations exerted synergistic growth-inhibitory and apoptosis-inducing effects in resistant cells, which indicates the role of ezrin in regulating vemurafenib resistance in BRAFV600E mutant melanoma. This evidence concerns the gene EZR and melanoma.